Columbia Financial, Inc. operates as a bank holding company for Columbia Bank that provides banking and other financial services to businesses and consumers in the United States. The company offers deposit products, including non-interest and interest-bearing demand accounts, savings and club deposits, money market accounts, and certificates of deposit. It also provides commercial loans, including multifamily and commercial real estate, commercial business, and construction loans; residential loans, such as one-to-four family residential real estate and one-to-four family residential loans; consumer loans, which includes home equity loans and advances, as well as automobile, personal, unsecured, and overdraft lines of credit; and securities activities. In addition, the company offers title insurance products; wealth management services; and cash management services comprising remote deposit, lockbox service, sweep accounts, and escrow services. Columbia Financial, Inc. was founded in 1926 and is based in Fair Lawn, New Jersey.…
3 Regional Bank Stocks Built For A Stronger US Dollar
Columbia Financial (NASDAQ: CLBK) is listed on Nasdaq, where its shares trade in USD. It belongs to the Banks - Regional industry, part of the Financial Services sector, and reports about 749 employees.
The shares were at 10.73 USD on 20 November 2026, up 55.0% over 52 weeks. Its 52-week range is 6.557 USD to 12.00 USD: the price is 10.6% below the high and 63.6% above the low.
At a market capitalisation of 2.89B USD, it trades at 35.8 times trailing earnings and 14.6 times forward earnings. The median trailing P/E of its 20 largest Banks - Regional peers is 10.3, a premium of 248% for CLBK. It pays a dividend yielding 1.85% (it pays out 10% of its earnings), against a median of 4.16% among the dividend payers in that peer group.
Columbia Financial reports return on equity of 4.5%, an operating margin of 27.0% and revenue up 12.4% year over year.
Its debt exceeds its cash by 1.08B USD, a debt-to-equity ratio of 1.02. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 14.17 USD is 32.0% above the current price. The next earnings report is expected on 2 February 2027.